We studied the effect of ovariectomy and estrogen replacement on expression of adrenal angiotensin II AT<sub>1</sub> and AT<sub>2</sub> receptors, aldosterone content, catecholamine synthesis, and the transcription factor Fos-related antigen 2 (Fra-2). Ovariectomy increased AT<sub>1</sub> receptor expression in the adrenal zona glomerulosa and medulla, and decreased adrenomedullary catecholamine content and Fra-2 expression when compared to intact female rats. In the zona glomerulosa, estrogen replacement normalized AT<sub>1</sub> receptor expression, decreased AT<sub>1B</sub> receptor mRNA, and increased AT<sub>2</sub> receptor expression and mRNA. Estrogen treatment decreased adrenal aldosterone content. In the adrenal medulla, the effects of estrogen replacement were: normalized AT<sub>1</sub> receptor expression, increased AT<sub>2</sub> receptor expression, AT<sub>2</sub> receptor mRNA, and tyrosine hydroxylase mRNA, and normalized Fra-2 expression and catecholamine content. We demonstrate that the constitutive adrenal expression of AT<sub>1</sub> receptors, catecholamine synthesis and Fra-2 expression are partially under the control of reproductive hormones. Our results suggest that estrogen treatment decreases aldosterone production through AT<sub>1</sub> receptor downregulation and AT<sub>2</sub> receptor upregulation. AT<sub>2</sub> receptor upregulation and modulation of Fra-2 expression may participate in the estrogen-dependent normalization of adrenomedullary catecholamine synthesis in ovariectomized rats. The AT<sub>2</sub> receptor upregulation and the decrease in AT<sub>1</sub> receptor function and in the production of the fluid-retentive, pro-inflammatory hormone aldosterone partially explain the protective effects of estrogen therapy.